U.S. COVID Case Rate Descent Hits Plateau
Key Points In today’s Recommendations for Industry, we discuss TAG’s weekly matrix, the plateauing of case rates, and what businesses need to be doing. Read
Key Points In today’s Recommendations for Industry, we discuss TAG’s weekly matrix, the plateauing of case rates, and what businesses need to be doing. Read
In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and recommendations for close contact, but vaccinated, workers who have no symptoms. Read more below.
In today’s Recommendations for Industry, we discuss TAG’s Weekly COVID-19 Matrix, U.S. and global hotspots, continued masking, and vaccine booster shots. Read more below. The
In today’s Recommendations for Industry, we discuss the conversations, news, and status of influenza, COVID-19, and their vaccines and vaccinations. Read more below. Research published
In today’s Recommendations for Industry, we discuss the risk matrix and the current decline of COVID-19 coinciding with the OSHA vaccination/testing standards. Read more below.
In today’s Recommendations for Industry, we discuss how to prepare for the OSHA vaccine and testing standards. Read more below. If you’re interested in how
In today’s Recommendations for Industry, we discuss the cautious optimism spurred by current COVID trends. Read more below. As you’ll see today in our Risk
In today’s Recommendations for Industry, we discuss the question: Is it Safe to Get the COVID-19 & Flu Vaccines at the Same Time? Read more
In today’s Recommendations for Industry, we discuss COVID post-infection antiviral medication trials that are nearing completion. Read more below. Viruses limited by COVID-19 restrictions may
In today’s Recommendations for Industry, we look at the Mu variant and the Flu Vaccine. Read more below. S. COVID-19 cases have reached 40 million